The Indian Pharmacopoeia Commission (IPC) issued a safety alert regarding Meftal, a commonly sold painkiller.
The drug's potential to cause a reaction known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) is an adverse reaction term that is currently used to describe a hypersensitivity reaction.
Experts classify DRESS syndrome as a type 4 hypersensitivity reaction.
It is a serious drug reaction affecting the skin and other organs, with a mortality rate of up to 10%.